$RLMD
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Healthcare
Sector
Biotechnology
Industry
Sergio Traversa
CEO
17
Employees
$4.07
Current Price
$299.20M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 2 | 4 | $1,671,990.00 | 400,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 2 | 4 | $1,671,990.00 | 400,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 2 | 4 | $1,671,990.00 | 400,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 2 | 4 | $1,671,990.00 | 400,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Shenouda Maged Chief Financial Officer | Purchase | 79,800 | $4.25 | $339,150.00 | View Details |
| Sep 9, 2026 | Shenouda Maged Chief Financial Officer | Purchase | 120,200 | $4.20 | $504,840.00 | View Details |
| Sep 9, 2026 | TRAVERSA SERGIO Director | Purchase | 100,000 | $4.18 | $418,000.00 | View Details |
| Sep 10, 2026 | TRAVERSA SERGIO Director | Purchase | 100,000 | $4.10 | $410,000.00 | View Details |
6 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Cluster Buy Signals
$RLMD appeared in 2 cluster buy signals: